Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
55,672,631
-
Share change
-
+1,338,657
-
Total reported value
-
$4,289,775,406
-
Put/Call ratio
-
65%
-
Price per share
-
$77.12
-
Number of holders
-
199
-
Value change
-
+$92,832,901
-
Number of buys
-
88
-
Number of sells
-
101
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q3 2018
As of 30 Sep 2018,
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,672,631 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, BB BIOTECH AG, STATE STREET CORP, Clearbridge Investments, LLC, and Woodford Investment Management Ltd.
This page lists
199
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.